ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $26,130 | +18.8% | 1,000 | 0.0% | 0.00% | – |
Q3 2022 | $22,000 | -24.1% | 1,000 | 0.0% | 0.00% | – |
Q2 2022 | $29,000 | +11.5% | 1,000 | 0.0% | 0.00% | – |
Q1 2022 | $26,000 | +13.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $23,000 | -23.3% | 1,000 | 0.0% | 0.00% | – |
Q3 2021 | $30,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2021 | $24,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q1 2021 | $18,000 | -5.3% | 1,000 | 0.0% | 0.00% | – |
Q4 2020 | $19,000 | +18.8% | 1,000 | 0.0% | 0.00% | – |
Q3 2020 | $16,000 | -15.8% | 1,000 | 0.0% | 0.00% | – |
Q2 2020 | $19,000 | +35.7% | 1,000 | 0.0% | 0.00% | – |
Q1 2020 | $14,000 | -30.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2019 | $20,000 | +5.3% | 1,000 | 0.0% | 0.00% | – |
Q3 2019 | $19,000 | -13.6% | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $22,000 | -38.9% | 1,000 | 0.0% | 0.00% | – |
Q1 2019 | $36,000 | -99.9% | 1,000 | -99.9% | 0.00% | -100.0% |
Q4 2018 | $24,755,000 | +4.9% | 838,894 | +50.9% | 0.15% | +22.2% |
Q3 2018 | $23,596,000 | +57451.2% | 555,994 | +55499.4% | 0.13% | – |
Q2 2018 | $41,000 | -28.1% | 1,000 | 0.0% | 0.00% | – |
Q1 2018 | $57,000 | +5.6% | 1,000 | 0.0% | 0.00% | – |
Q4 2017 | $54,000 | +8.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2017 | $50,000 | -12.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2017 | $57,000 | -1.7% | 1,000 | 0.0% | 0.00% | – |
Q1 2017 | $58,000 | +5.5% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $55,000 | +17.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $47,000 | +9.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $43,000 | +26.5% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $34,000 | -57.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $79,000 | +36.2% | 1,000 | 0.0% | 0.00% | – |
Q3 2015 | $58,000 | -9.4% | 1,000 | 0.0% | 0.00% | – |
Q2 2015 | $64,000 | +6.7% | 1,000 | 0.0% | 0.00% | – |
Q1 2015 | $60,000 | +3.4% | 1,000 | 0.0% | 0.00% | – |
Q4 2014 | $58,000 | +38.1% | 1,000 | 0.0% | 0.00% | – |
Q3 2014 | $42,000 | -16.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2014 | $50,000 | +13.6% | 1,000 | 0.0% | 0.00% | – |
Q1 2014 | $44,000 | +10.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2013 | $40,000 | +21.2% | 1,000 | 0.0% | 0.00% | – |
Q3 2013 | $33,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2013 | $33,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |